Multimodal targeting chimeras enable integrated immunotherapy leveraging tumor-immune microenvironment.
Lin F, Yin S, Zhang Z, Yu Y, Fang H, Liang Z, Zhu R, Zhou H, Li J, Cao K, Guo W, Qin S, Zhang Y, Lu C, Li H, Liu S, Zhang H, Ye B, Lin J, Li Y, Kang X, Xi JJ, Chen PR.
Lin F, et al. Among authors: zhu r.
Cell. 2024 Nov 2:S0092-8674(24)01198-X. doi: 10.1016/j.cell.2024.10.016. Online ahead of print.
Cell. 2024.
PMID: 39504957